CoChat

Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?

Mave, V., Garcia-Diaz, J., Islam, T., Hasbun, R. · 2009 · Journal of Antimicrobial Chemotherapy

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The treatment of vancomycin-resistant enterococcal (VRE) bacteraemia remains challenging. Daptomycin is a new antibiotic with bactericidal activity against VRE, but available clinical data are limited. METHODS: A retrospective study was performed on 98 adult patients with VRE bacteraemia admitted to two hospitals between September 2003 and December 2007 to compare the efficacy of daptomycin with that of linezolid. Multivariable analyses were performed to compare the microbiological and clinical outcomes of both groups. RESULTS: Out of 98 patients with VRE bacteraemia, 68 were treated with linezolid and 30 with daptomycin. Univariate analyses showed no significant differences between the groups regarding baseline demographic and clinical characteristics, severity of illness and co-morbidity. Daptomycin was associated with a trend towards a higher mortality rate (26.7% versus 20.6%), longer median duration of bacteraemia (3 days versus 2 days) and higher relapse rate (6.7% versus 2.9%), but these differences did not reach statistical significance (P > 0.2). Microbiological cure rates were 90% for the daptomycin group and 88.2% for the linezolid group (P = 0.92). CONCLUSIONS: Despite a trend towards worse outcomes, daptomycin was as effective as linezolid in treating VRE bacteraemia. A randomized clinical trial is needed to confirm these results.

Overview

Integrity signals

Registry

Crossref · 10.1093/jac/dkp154

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 27 references

Cited by

See all 67

Metadata

Authors
Mave, V., Garcia-Diaz, J., Islam, T., & Hasbun, R.
Affiliations
  • Tulane University (US)
  • The University of Texas Health Science Center at Houston (US)
Corresponding author
Hasbun, R.
Venue
Journal of Antimicrobial Chemotherapy
Published
2009-05-07
Volume
64
Issue
1
Pages
175-180
ISSN
  • 0305-7453 (ISSN-L)
  • 1460-2091
OpenAlex
W2170330952
Cited by
65
References
27
Citations by year
2025: 2 · 2023: 2 · 2022: 2 · 2019: 3 · 2017: 4 · 2016: 3 · 2015: 7 · 2014: 11 · 2013: 5 · 2012: 11
FWCI
4.16
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Antimicrobial Chemotherapy (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
  • Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Keywords
vancomycin-resistant enterococci, bacteremia, daptomycin, linezolid, antibiotic efficacy comparison, mortality, relapse, microbiological cure, bactericidal activity
MeSH terms
Linezolid, Acetamides, Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents, Female, Humans, Male, Middle Aged, Retrospective Studies, Bacteremia, Treatment Outcome, Gram-Positive Bacterial Infections, Enterococcus, Daptomycin, Vancomycin Resistance, Oxazolidinones, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid? https://app.cochat.ai/papers/10.1093/jac/dkp154
The paper
Mave, V., Garcia-Diaz, J., Islam, T., & Hasbun, R. (2009). Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid? Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkp154

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.